Abstract:Lung cancer is the leading cause of cancer death worldwide, and squamous carcinoma is the most common histological subtype. Clinical and molecular evidence indicated that lung squamous carcinoma is heterogeneous disease. Long non-coding RNAs (lncRNAs) were noncoding RNAs with more than 200 nucleotide length. They have been found to be involved in a variety of biological processes. Many studies indicated that they were aberrantly expressed in some types of carcinomas. In this study, we tested the hypothesis that some lncRNAs may correlate with lung cancer tumor genesis by detecting genome-scale lncRNAs expressions. 16 lung squamous cell carcinoma patients’paired normal and lung tumor tissues were obtained after surgery. First, extracted total RNA from frozen tissues by Trizol reagent; next, reverse-transcripted the total RNA to cDNA, got cRNA in vitro transcription synthesis, and then purified cRNA by spin columns, cRNA was transcribed into cDNA utilizing a random priming method and cDNA was labeled and hybridized to the Agilent human 4×180 K microarray. Processed signal data was obtained from hybridized images using Agilent Feature Extraction. Quantile normalization and differential expression data were performed using the Agilent GeneSpring. Data analyses were performed using R and Bioconductor. With abundant and varied probes accounting 38,361 lncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 28,055. From the results we found that there were 3,460 lncRNAs that differentially expressed (≥ 2 absolute fold-change) in lung squamous cell carcinoma tissues compared with normal tissue, among which 127 lncRNAs differentially expressed in all 16 lung squamous cell carcinoma samples. Our study is the first one to determine genome-wide lncRNAs expression patterns in lung squamous cell carcinoma by using microarray. The results indicated that clusters of lncRNAs were significantly differentially expressed. Of all 3,460 differentially expressed lncRNAs, 1901 lncRNAs were up-regulated and 1559 down-regulated. 9/16 lung squamous cell carcinoma patients’up-regulated lncRNAs were more common than down-regulated ones. 7/16 patients down-regulated lncRNAs were more common than up-regulated ones. To predict the functions of lncRNAs, we constructed coding–non-coding gene co-expression networks of lncRNAs and mRNAs, on the basic of correlation cutoff 0.99 and P-value<0.05. We searched lncRNAmRNA pairs whose distance of genomic locations was less than 10kb. In addition, we blatted the sequences of lncRNA and 3‘UTR of mRNAs to screen the sequence similarity lncRNA-mRNA pairs. We then got 33 lncRNA-mRNA pairs. The mRNAs of pairs were considered the target genes of lncRNAs. From the mRNAs, we found that TERC was likely a useful biomarker for the diagnosis of the non-small cell carcinoma. As the ENST00000363312 and sno-RNA_scaRNA_0_548 also had the similar function, we considered that they were likely useful biomarkers for the diagnosis of the non-small cell carcinoma. We concluded that lncRNAs differentially expressed in lung tumor tissues and normal tissues may exert a partial or key role in lung tumor development, and may provide potential targets for future treatment of lung squamous cell carcinoma.

Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.

Analysis of Microarray Data on Gene Expression and Methylation to Identify Long Non-coding RNAs in Non-small Cell Lung Cancer

Genome-wide Analysis of Long Non-Coding RNA Expression and Function in Colorectal Cancer

Identification of Long Noncoding Rnas for the Detection of Early Stage Lung Squamous Cell Carcinoma by Microarray Analysis

Identification of Biomarkers for the Detection of Early Stage Lung Adenocarcinoma by Microarray Profiling of Long Noncoding RNAs.

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Circulating Long Noncoding RNA Act As Potential Novel Biomarkers for Diagnosis and Prognosis of Non‐small Cell Lung Cancer

Detection of long-chain non-encoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification.

Differential expression of lone non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors

Genome-scale lncRNAs Expressions Pattern in Lung Squamous Carcinoma

Identification of Long Non-Coding RNA Signatures for Squamous Cell Carcinomas and Adenocarcinomas

Characterization of Micrornas and Lncrnas in Early-Stage Squamous Cell Carcinoma Based on the Analysis of TCGA Datasets

Analysis of Lncrna Expression Profiles in Non-Small Cell Lung Cancers (NSCLC) and Their Clinical Subtypes

Identification of Long Non-Coding RNA 00312 and 00673 in Human NSCLC Tissues

Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.

LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data

Transcriptional Profiling Analysis And Functional Prediction Of Long Noncoding Rnas In Cancer

Identification and Functional Characterization of Long Non-Coding RNAs in Human Gastric Cancer.

Identification Of Novel Biomarkers And Candidate Small Molecule Drugs In Non-Small-Cell Lung Cancer By Integrated Microarray Analysis